Proteostasis Therapeutics to Present at Upcoming Investor

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Proteostasis Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc . (NASDAQ: PTI ), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as cystic fibrosis (CF), today announced that Meenu Chhabra, president and chief executive officer of Proteostasis Therapeutics, will present at the following upcoming investor conferences:

  • Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series on Wednesday, September 28, 2016 at 2:05 p.m. ET in New York City.
  • Jefferies Cystic Fibrosis Summit on Thursday, September 29, 2016 at 8:45 a.m. ET in New York City.

A live audio webcast of the Leerink Partners presentation will be available on the Event Calendar page in the Investors & Media section of the Company’s website, www.proteostasis.com . A replay of the webcast will be available on the Company’s website following the presentation.

About Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery of groundbreaking therapies to treat diseases caused by dysfunctional protein processing, such as cystic fibrosis (CF). Headquartered in Cambridge, MA, the Proteostasis Therapeutics team focuses on identifying therapies that modulate the proteostasis imbalance in cells and restore protein function. Proteostasis Therapeutics is currently enrolling eligible adults with CF to participate in its Phase 1 clinical trials of PTI-428. PTI-428 is a unique modulator of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, called an amplifier, that when used in combination with existing treatments and therapies has shown a consistent positive effect on CFTR protein activity in vitro in pre-clinical studies. In addition to its multiple programs in cystic fibrosis, Proteostasis Therapeutics has formed collaborations with Biogen to research and identify therapeutic candidates for neurodegenerative disease and with Astellas Pharma, Inc. to research and identify therapies targeting the Unfolded Protein Response (UPR) pathway. For more information, visit www.proteostasis.com . 

Media Contact: Katie Engleman, Pure Communications, Inc. (910) 509-3977 katie@purecommunicationsinc.com Investor Contact: Luke Heagle, Pure Communications, Inc. (910) 726-1372 luke@purecommunicationsinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thunderly Bags Davey Awards for Creative Franchise Videos

Updated Category News Views 87

Big Wins from Humble Beginnings Ever notice how some small outfits have a knack for punching above their weight? Thunderly, a Dallas-based marketing agency, is a shining example of that. They've just snagged two Silver Awards at the 22nd Annual Davey Awards—and it’s stirring up talk across the sector. Winning a Davey isn’t child's play; it’s about small teams...

Continue Reading
Jacquie Lawson's Advent Calendar Delights Fans for 17th Year

Updated Category News Views 41

A Festive Tradition with a Twist The Jacquie Lawson Advent calendar is back for its 17th season, and it's no ho-hum affair. This time, the scene is set against the breathtaking backdrop of England's Lake District. If you've been yearning for a bit of that classic literary and natural charm, this is your ticket—minus the airfare. The calendar isn't just a countdown; it's...

Continue Reading
Jack Henry's Q1 2027 Deconversion Revenue Hits $17.9M

Updated Category News Views 49

Jack Henry Surprises with Strong Deconversion Revenue You're probably thinking, deconversion revenue—what on earth is that? Imagine you're in the financial tech business and one of your bigwig clients decides to merge or get gobbled up by another institution. They move shop, and voila, you've got some unexpected money flowing in due to that exit. That's deconversion...

Continue Reading
Courtney Clark to Keynote Stronger to Serve 2027

Updated Category News Views 75

Wipfli Sets the Stage for a Transformative Conference Wipfli, the heavyweight in advisory and accounting, is gathering the who's who of nonprofit and mission-driven leaders. But this time, they're putting a spotlight on resilience and adaptability. They're bringing in none other than Courtney Clark for the 2027 Stronger to Serve Conference slated for July 12-15 in...

Continue Reading
Bitcoin Mortgages: APX Ushers in New Canadian Era

Updated Category News Views 59

Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...

Continue Reading
xTool X1: Redefining Laser Fabrication for Makers

Updated Category News Views 140

The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...

Continue Reading
American Lung Association's Bold $21M Research Investment

Updated Category News Views 25

Pumping Life into Lung Health Research The American Lung Association (ALA) just announced a jaw-dropping $21 million investment this year into lung health research. That's right, while some are counting beans, ALA is diving headfirst into serious health challenges plaguing millions of Americans. They've pumped hundreds of millions in the past decade, totaling $193...

Continue Reading
Cerebras Faces Durability Allegations: Investor Alert

Updated Category News Views 57

Cracks in Cerebras' Processor Promises? When you dance with high-stakes tech stocks, sometimes you end up stepping on a few toes. This seems to ring true as Cerebras Systems (CBRS) dances its way into hot water. Allegations from Culper Research suggest their fancy AI processors, which are supposed to be the poster children of reliability, might bow out early. Digging...

Continue Reading
Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 79

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading
Digital Science's Game-Changing Jenni AI Acquisition

Updated Category News Views 225

A Strategic Move in the Research Sector When you're dealing with tech giants and their endless race to corner niche markets, it's the big moves that really catch one's attention. The latest acquisition on the block is Digital Science picking up Jenni AI, a platform trusted by over 8 million students and researchers scattered across 189 countries. Now, that's a hefty user...

Continue Reading
/news?page=2">More News Articles